Seasoned investor and operator with a focus on growth-stage technology and healthcare opportunities, bringing experience across venture capital, corporate strategy and board advisory roles. Karen Tatman combines deal-sourcing and portfolio-management skills with operational insight to support scaling companies, capital raises and M&A execution. Regularly engages with founders and management teams on go-to-market, financial planning and governance; known for constructing syndicates and advising on exit pathways. Market-facing profile appeals to LPs seeking experienced GP collaboration and strategic value-add in complex sectors.
Seasoned investor and operator with a focus on growth-stage technology and healthcare opportunities, bringing experience across venture capital, corporate strategy and board advisory roles. Karen Tatman combines deal-sourcing and portfolio-management skills with operational insight to support scaling companies, capital raises and M&A execution. Regularly engages with founders and management teams on go-to-market, financial planning and governance; known for constructing syndicates and advising on exit pathways. Market-facing profile appeals to LPs seeking experienced GP collaboration and strategic value-add in complex sectors.
Targets growth-stage technology and healthcare companies, applying an operator-investor mindset that prioritizes revenue acceleration, capital efficiency and durable unit economics. Deploys conviction-led, staged capital with active board-level governance and hands-on go-to-market and financial planning support. Emphasizes syndicate construction, exit pathway optimization and LP alignment, favoring scalable models where operational leverage and M&A optionality shorten time to liquidity.
Targets growth-stage technology and healthcare companies, applying an operator-investor mindset that prioritizes revenue acceleration, capital efficiency and durable unit economics. Deploys conviction-led, staged capital with active board-level governance and hands-on go-to-market and financial planning support. Emphasizes syndicate construction, exit pathway optimization and LP alignment, favoring scalable models where operational leverage and M&A optionality shorten time to liquidity.
| Trades 55 | Longs Won 48/55 87% | Profit Factor 235.26 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.33M |
| Average Win $1.13M | Best Trade (Oct 06) $18.04M | Sharpe Ratio -59.44 |
| Average Loss -$33,041.65 | Worst Trade (Mar 30) -$63,766.3 | Z-Score 17.12 (100%) |
| Commissions $0 | Avg. Trade Length 1y 6d | Expectancy $985,117.18 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 1.73% |
| Consecutive Losing Trades | 6,623 | 5,960 | 5,298 | 4,636 | 3,974 | 3,311 | 2,649 | 1,987 | 1,325 | 662 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 1,949 | $460,740.57 | $648,939.04 | - | $188,198.47 | 40.85% | +0.021% |
AVGO Broadcom Inc. | 790 | $217,763.9 | $299,591.7 | - | $81,827.8 | 37.58% | +4.612% |
CGDV Capital Group Dividend Value ETF | 6,187 | $220,505 | $308,628.6 | - | $88,123.6 | 39.96% | +0.653% |
CGGO Capital Group Global Growth Equity ETF | 10,286 | $291,402 | $414,011.5 | - | $122,609.5 | 42.08% | +0.149% |
DFAS Dimensional U.S. Small Cap ETF | 90,461 | $5.89M | $7.16M | - | $1.27M | 21.54% | +0.032% |
HD The Home Depot, Inc. | 621 | $227,590 | $176,935.32 | - | -$50,654.68 | -22.26% | +1.341% |
IJR iShares Core S&P Small-Cap ETF | 8,383 | $961,739.4 | $1.16M | - | $202,575.47 | 21.06% | -0.094% |
IVV iShares Core S&P 500 ETF | 100,107 | $59.18M | $78.45M | - | $19.26M | 32.55% | +0.694% |
MSFT Microsoft Corp. | 1,484 | $586,404.64 | $788,857.3 | - | $202,452.66 | 34.52% | +1.218% |
NVDA NVIDIA Corporation | 1,405 | $188,677.76 | $337,445.87 | - | $148,768.11 | 78.85% | +0.534% |
SCHA Schwab U.S. Small-Cap ETF | 7,311 | $212,604 | $242,176.87 | - | $29,572.87 | 13.91% | -0.346% |
SCHM Schwab U.S. Mid-Cap ETF | 9,559 | $295,947 | $333,704.69 | - | $37,757.69 | 12.76% | +0.403% |
SPY SPDR S&P 500 ETF Trust | 3,314 | $1.97M | $2.59M | - | $612,484.84 | 31.04% | +0.693% |
VOO Vanguard S&P 500 ETF | 4,007 | $2.16M | $2.87M | - | $717,763.29 | 33.3% | +0.675% |
VTEB Vanguard Tax-Exempt Bond ETF | 20,300 | $1.01M | $960,393 | - | -$52,374 | -5.17% | -0.127% |
VTI VANGUARD TOTAL STOCK MKT ETF | 291,438 | $84.53M | $111.63M | - | $27.11M | 32.07% | +0.641% |
VXUS Vanguard Total International Stock Index Fund Investor Shares | 120,171 | $7.08M | $10.34M | - | $3.26M | 46.03% | +0.239% |